Patent · US Active

11 β-HSD1 modulators

US8163771B2 · kind B2 · utility

0Cited by

0References

40Claims

0Family size

Assignee

Exelixis, Inc. · US

Inventors

Richard Martin · San Diego, US
Brenton T. Flatt · Poway, US
Jackline E. Dalgard · Del Mar, US
Venkataiah Bollu · San Diego, US
Ping Huang · Mountain View, US
Raju Mohan · Encinitas, US
Edwin Schweiger · San Diego, US
Tie-Lin Wang · Shanghai, CN

Key dates

Filing date	Mar 13, 2009
Grant date	Apr 24, 2012
Priority date	—
Expiry date	Jun 12, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound according to Formula I:or a pharmaceutically acceptable salt thereof, wherein R1, R2, R11, L1 and X are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.